Pentwater Capital Management’s Celgene Corp CELG Stock Holding History

Pentwater Capital Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,940,000	Closed	-$193M	–	207
2019 Q3	$193M	Sell	1,940,000 -1,215,000	-39%	-$115M	3.01%	9
2019 Q2	$292M	Sell	3,155,000 -8,531,200	-73%	-$810M	3.13%	6
2019 Q1	$1.1B	Buy	+11,686,200	New	+$1.02B	13.91%	1

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Pentwater Capital Management's CELG Position: Q4 2019 in Review

Pentwater Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 6,197,680 shares — an estimated $615M sold.

Pentwater Capital Management first reported a position in CELG in Q1 2019 and held it in 3 quarters. The position peaked at $923M in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Pentwater Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Pentwater Capital Management sold 6,197,680 Celgene Corp shares in Q4 2019, an estimated $615M.
Pentwater Capital Management first reported a position in Celgene Corp in Q1 2019 and held it in 3 quarters.
Pentwater Capital Management's Celgene Corp position peaked at $923M in Q1 2019.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Pentwater Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.